139 related articles for article (PubMed ID: 17983599)
1. Anti-obesity and anti-tumor pro-apoptotic peptides are sufficient to cause release of cytochrome c from vesicles.
Sandoval CM; Salzameda B; Reyes K; Williams T; Hohman VS; Plesniak LA
FEBS Lett; 2007 Nov; 581(28):5464-8. PubMed ID: 17983599
[TBL] [Abstract][Full Text] [Related]
2. Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity.
Arzoine L; Zilberberg N; Ben-Romano R; Shoshan-Barmatz V
J Biol Chem; 2009 Feb; 284(6):3946-55. PubMed ID: 19049977
[TBL] [Abstract][Full Text] [Related]
3. Orientation and helical conformation of a tissue-specific hunter-killer peptide in micelles.
Plesniak LA; Parducho JI; Ziebart A; Geierstanger BH; Whiles JA; Melacini G; Jennings PA
Protein Sci; 2004 Aug; 13(8):1988-96. PubMed ID: 15273301
[TBL] [Abstract][Full Text] [Related]
4. A lactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-60).
Onishi J; Roy MK; Juneja LR; Watanabe Y; Tamai Y
J Pept Sci; 2008 Sep; 14(9):1032-8. PubMed ID: 18425992
[TBL] [Abstract][Full Text] [Related]
5. Condensates of short peptides and ATP for the temporal regulation of cytochrome c activity.
Saha B; Chatterjee A; Reja A; Das D
Chem Commun (Camb); 2019 Dec; 55(94):14194-14197. PubMed ID: 31702760
[TBL] [Abstract][Full Text] [Related]
6. Interaction of hydrophobic peptides with model membranes: slow binding to membranes and not subtle variations in pore structure is responsible for the gradual release of entrapped solutes.
Saberwal G; Nagaraj R
Biochim Biophys Acta; 1993 Sep; 1151(1):43-50. PubMed ID: 8357819
[TBL] [Abstract][Full Text] [Related]
7. A peptide inhibitor of cytochrome c/inositol 1,4,5-trisphosphate receptor binding blocks intrinsic and extrinsic cell death pathways.
Boehning D; van Rossum DB; Patterson RL; Snyder SH
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1466-71. PubMed ID: 15665074
[TBL] [Abstract][Full Text] [Related]
8. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
9. Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex.
Twiddy D; Brown DG; Adrain C; Jukes R; Martin SJ; Cohen GM; MacFarlane M; Cain K
J Biol Chem; 2004 May; 279(19):19665-82. PubMed ID: 14993223
[TBL] [Abstract][Full Text] [Related]
10. Effect of the CRAC Peptide, VLNYYVW, on mPTP Opening in Rat Brain and Liver Mitochondria.
Azarashvili T; Krestinina O; Baburina Y; Odinokova I; Akatov V; Beletsky I; Lemasters J; Papadopoulos V
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983605
[TBL] [Abstract][Full Text] [Related]
11. Cellular Membrane Composition Requirement by Antimicrobial and Anticancer Peptide GA-K4.
Mishig-Ochir T; Gombosuren D; Jigjid A; Tuguldur B; Chuluunbaatar G; Urnukhsaikhan E; Pathak C; Lee BJ
Protein Pept Lett; 2017; 24(3):197-205. PubMed ID: 27993125
[TBL] [Abstract][Full Text] [Related]
12. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.
Chu F; Borthakur A; Sun X; Barkinge J; Gudi R; Hawkins S; Prasad KV
Apoptosis; 2004 Jan; 9(1):83-95. PubMed ID: 14739602
[TBL] [Abstract][Full Text] [Related]
13. Transient vesicle leakage initiated by a synthetic apoptotic peptide derived from the death domain of neurotrophin receptor, p75NTR.
Medina ML; Chapman BS; Bolender JP; Plesniak LA
J Pept Res; 2002 Apr; 59(4):149-58. PubMed ID: 11972750
[TBL] [Abstract][Full Text] [Related]
14. Membrane fusion activity of the influenza virus hemagglutinin: interaction of HA2 N-terminal peptides with phospholipid vesicles.
Rafalski M; Ortiz A; Rockwell A; van Ginkel LC; Lear JD; DeGrado WF; Wilschut J
Biochemistry; 1991 Oct; 30(42):10211-20. PubMed ID: 1931950
[TBL] [Abstract][Full Text] [Related]
15. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
Shangary S; Johnson DE
Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
[TBL] [Abstract][Full Text] [Related]
16. Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity.
Chu DS; Bocek MJ; Shi J; Ta A; Ngambenjawong C; Rostomily RC; Pun SH
J Control Release; 2015 May; 205():155-61. PubMed ID: 25596326
[TBL] [Abstract][Full Text] [Related]
17. Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles.
Nicol F; Nir S; Szoka FC
Biophys J; 2000 Feb; 78(2):818-29. PubMed ID: 10653794
[TBL] [Abstract][Full Text] [Related]
18. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS
BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585
[TBL] [Abstract][Full Text] [Related]
19. Destabilization of membranes containing cardiolipin or its precursors by peptides derived from mitogaligin, a cell death protein.
Gonzalez P; Duneau M; Charpentier S; Normand T; Mollet L; Dubois M; Legrand A
Biochemistry; 2007 Jun; 46(25):7374-82. PubMed ID: 17547372
[TBL] [Abstract][Full Text] [Related]
20. Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores.
Wimley WC; Selsted ME; White SH
Protein Sci; 1994 Sep; 3(9):1362-73. PubMed ID: 7833799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
